Teligent, Inc. (TLGT) Shares Bought by Pembroke Management LTD
Pembroke Management LTD lifted its stake in shares of Teligent, Inc. (NASDAQ:TLGT) by 2.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,326,621 shares of the company’s stock after acquiring an additional 65,200 shares during the quarter. Pembroke Management LTD owned 4.36% of Teligent worth $15,612,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cortina Asset Management LLC boosted its stake in shares of Teligent by 47.7% during the 3rd quarter. Cortina Asset Management LLC now owns 922,507 shares of the company’s stock worth $6,190,000 after acquiring an additional 297,995 shares in the last quarter. Columbus Circle Investors boosted its stake in shares of Teligent by 54.6% during the 3rd quarter. Columbus Circle Investors now owns 276,472 shares of the company’s stock worth $1,855,000 after acquiring an additional 97,642 shares in the last quarter. Suffolk Capital Management LLC boosted its stake in shares of Teligent by 41.3% during the 3rd quarter. Suffolk Capital Management LLC now owns 214,214 shares of the company’s stock worth $1,437,000 after acquiring an additional 62,644 shares in the last quarter. New Jersey Better Educational Savings Trust boosted its stake in shares of Teligent by 25.0% during the 3rd quarter. New Jersey Better Educational Savings Trust now owns 50,000 shares of the company’s stock worth $336,000 after acquiring an additional 10,000 shares in the last quarter. Finally, Summit Creek Advisors LLC boosted its stake in shares of Teligent by 15.6% during the 3rd quarter. Summit Creek Advisors LLC now owns 795,853 shares of the company’s stock worth $5,340,000 after acquiring an additional 107,245 shares in the last quarter. 67.70% of the stock is owned by institutional investors and hedge funds.
Shares of Teligent, Inc. (NASDAQ TLGT) traded down $0.06 during trading on Wednesday, hitting $3.32. The stock had a trading volume of 621,100 shares, compared to its average volume of 420,807. The company has a quick ratio of 2.71, a current ratio of 3.28 and a debt-to-equity ratio of 2.23. Teligent, Inc. has a 1-year low of $2.82 and a 1-year high of $9.54.
Teligent (NASDAQ:TLGT) last issued its earnings results on Monday, November 6th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.07). The business had revenue of $13.65 million during the quarter, compared to analyst estimates of $19.12 million. Teligent had a negative return on equity of 6.51% and a negative net margin of 16.95%. The business’s quarterly revenue was down 15.5% on a year-over-year basis. During the same period last year, the business earned $0.01 EPS. analysts predict that Teligent, Inc. will post -0.2 earnings per share for the current fiscal year.
Several research firms have recently weighed in on TLGT. Canaccord Genuity reissued a “buy” rating and set a $11.00 price objective on shares of Teligent in a research note on Tuesday, August 8th. Roth Capital set a $9.00 price objective on Teligent and gave the stock a “buy” rating in a research note on Wednesday, August 9th. BidaskClub lowered Teligent from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. ValuEngine lowered Teligent from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Finally, TheStreet lowered Teligent from a “c-” rating to a “d+” rating in a research note on Wednesday, November 1st. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $7.33.
Teligent Company Profile
Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.
Want to see what other hedge funds are holding TLGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teligent, Inc. (NASDAQ:TLGT).
Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.